These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20578219)

  • 1. Closing one hole leads to another: delayed aortic perforation following closure of a patent foramen ovale.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):135-6. PubMed ID: 20578219
    [No Abstract]   [Full Text] [Related]  

  • 2. Late aortic perforation with an Atriasept device resulting in life-threatening tamponade.
    Murphy JC; Walsh SJ; Spence MS
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):132-4. PubMed ID: 20578098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device closure of patent foramen ovale--do similar devices achieve similar results?
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):715. PubMed ID: 21433274
    [No Abstract]   [Full Text] [Related]  

  • 4. Malpositioned PFO device repair after the fact. Percutaneously? Really?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):782-3. PubMed ID: 20333774
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

  • 6. Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
    Meier B
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):652. PubMed ID: 19780059
    [No Abstract]   [Full Text] [Related]  

  • 7. Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?
    DiBardino DJ; Mayer JE
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):222-3. PubMed ID: 21683840
    [No Abstract]   [Full Text] [Related]  

  • 8. Snares for embolized septal occluders: retrieval of tangled, twisted, and mangled devices in structural heart intervention.
    Feldman T
    Catheter Cardiovasc Interv; 2011 May; 77(6):901-2. PubMed ID: 21520388
    [No Abstract]   [Full Text] [Related]  

  • 9. Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
    Aaron S; Mainzer G; Lorber A
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):678-80. PubMed ID: 21805618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 11. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent foramen ovale and migraine headaches: the saga continues.
    Tobis J
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous retrieval of the locked helex septal occluder.
    Poommipanit P; Levi D; Shenoda M; Tobis J
    Catheter Cardiovasc Interv; 2011 May; 77(6):892-900. PubMed ID: 20853357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D; Fabbiocchi F; Montorsi P; Galli S; Teruzzi G; Grancini L; Gatto P; Bartorelli AL
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):570-4. PubMed ID: 21351231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
    Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late patent foramen ovale occluder device embolization.
    Gaspardone A; Giardina A; Gioffrè G; Iamele M; Borioni R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):282-4. PubMed ID: 21386687
    [No Abstract]   [Full Text] [Related]  

  • 19. Unexpected perforation leading to life-threatening cardiac tamponade six years after patent foramen ovale closure with an intrasept device.
    Vandeloo B; Dymarkowski S; Budts W
    Acta Cardiol; 2016 Apr; 71(2):247-8. PubMed ID: 27090049
    [No Abstract]   [Full Text] [Related]  

  • 20. Hybrid peratrial double device closure of a patent foramen ovale and sinus venosus defect in an infant with vein of Galen malformation.
    Delaney JW; Thorell WE; Hammel JM
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1045-50. PubMed ID: 21542115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.